Maureen Connelly to Estrogen Replacement Therapy
This is a "connection" page, showing publications Maureen Connelly has written about Estrogen Replacement Therapy.
Connection Strength
0.844
-
Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995. J Gen Intern Med. 2000 Aug; 15(8):542-50.
Score: 0.175
-
Patient knowledge about hormone replacement therapy: implications for treatment. Menopause. 2000 Jul-Aug; 7(4):266-72.
Score: 0.174
-
Patient-identified needs for hormone replacement therapy counseling: a qualitative study. Ann Intern Med. 1999 Aug 17; 131(4):265-8.
Score: 0.164
-
Hormone therapy initiation after the Women's Health Initiative. Menopause. 2008 May-Jun; 15(3):487-93.
Score: 0.075
-
The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative. J Gen Intern Med. 2005 Apr; 20(4):350-6.
Score: 0.061
-
Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr. 2005; (35):106-12.
Score: 0.060
-
Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. J Natl Cancer Inst Monogr. 2005; (35):113-5.
Score: 0.060
-
Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004 Nov; 104(5 Pt 1):1042-50.
Score: 0.059
-
How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes. J Gen Intern Med. 2007 Sep; 22(9):1311-6.
Score: 0.018